Risk Factors in Coronary Heart Disease: An Evaluation of Several Serum Lipids as Predictors of Coronary Heart Disease: The Framingham Study
Authors: WILLIAM B. KANNEL
Journal: Annals of Internal Medicine (1964)

Article1 November 1964Risk Factors in Coronary Heart DiseaseThe Framingham StudyWILLIAM B. KANNEL, M.D., F.A.C.P., THOMAS R. DAWBER, M.D., F.A.C.P., GARY D. FRIEDMAN, M.D., WILLIAM E. GLENNON, M.S., PATRICIA M. MCNAMARAWILLIAM B. KANNEL, M.D., F.A.C.P.Search for more papers by this author, THOMAS R. DAWBER, M.D., F.A.C.P.Search for more papers by this author, GARY D. FRIEDMAN, M.D.Search for more papers by this author, WILLIAM E. GLENNON, M.S.Search for more papers by this author, PATRICIA M. MCNAMARASearch for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-61-5-888 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptAt Framingham, Massachusetts, the National Heart Institute has been following 5,127 men and women aged 30 to 60 years in a study of factors related to the development of coronary heart disease (CHD) and hypertension. Data for a decade of follow-up studies of this population are available for analysis.From a study of those who have developed disease under observation in comparison to those who have remained free of the disease, factors of risk and susceptible individuals have been identified. The factors associated with excess risk that have been identified are: serum cholesterol level, blood pressure, cigarette smoking, vital capacity,...References1. GORDONMOORESHURTLEFFDAWBER TFEDTR: Some methodologic problems in the long-term study of cardiovascular disease: observations on the Framingham Study. J. Chron. Dis. 10: 186, 1959. CrossrefGoogle Scholar2. KANNELDAWBERKAGANREVOTSKIESTOKES WBTRANJ: Factors of risk in the development of coronary heart disease—six-year follow-up experience: The Framingham Study. Ann. Intern. Med. 55: 33, 1961. LinkGoogle Scholar3. KAHN HA: A method for analyzing longitudinal observations on individuals in the Framingham Heart Study. Proceedings of the Social Statistics Section of the American Statistical Association, 1961. Google Scholar4. DELALLAGOFMAN OFJW: Ultracentrifugal analysis of serum lipoprotein, in Methods of Biochemical Analysis, vol. 1, edited by GLICK, D., Interscience, New York, 1954, pp. 459-478. Google Scholar5. ABELLLEVYBRODIEKENDALL LLBBBBFE: A simplified method for estimation of total cholesterol in serum and demonstration of its specificity. J. Biol. Chem. 195: 357, 1952. CrossrefMedlineGoogle Scholar6. YOUNGBURGYOUNGBURG GEMV: Phosphorus metabolism; system of blood phosphorus analysis. J. Lab. Clin. Med. 16: 158, 1930. Google Scholar7. FISKESUBARROW CHY: The colorimetric determination of phosphorus. J. Biol. Chem. 66: 375, 1925. CrossrefGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Framingham, MassachusettsFrom the Heart Disease Epidemiology Study, Framingham, Mass., and the National Heart Institute, National Institutes of Health, U. S. Public Health Service, Bethesda, Md.Requests for reprints should be addressed to William B. Kannel, M.D., Heart Disease Epidemiology Study, Dept. of Health, Education, and Welfare, 25 Evergreen St., Framingham, Mass. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited ByLEGACY: Phase 2a Trial to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamic Effects of the Anti-EL (Endothelial Lipase) Antibody MEDI5884 in Patients With Stable Coronary Artery DiseaseEfficacy of dulaglutide on vascular health indexes in subjects with type 2 diabetes: a randomized trialGenetic Determinants of Plasma Low-Density Lipoprotein Cholesterol Levels: Monogenicity, Polygenicity, and “Missing” HeritabilityGesättigte Fettsäuren und kardiovaskuläres RisikoThe burden of cholesterol accumulation through the lifespan: why pharmacological intervention should start earlier to go further?Is a High HDL-Cholesterol Level Always Beneficial?Milk fat: opportunities, challenges and innovationRisk and protective factors for intuitive and rational judgment of cybersecurity risks in a large sample of K-12 students and teachersLong-term exposure to ambient air pollution is associated with coronary artery calcification among asymptomatic adultsADAM17 Boosts Cholesterol Efflux and Downstream Effects of High-Density Lipoprotein on Inflammatory Pathways in MacrophagesRapid Decrease in HDL-C in the Puberty Period of Boys Associated with an Elevation of Blood Pressure and Dyslipidemia in Korean Teenagers: An Explanation of Why and When Men Have Lower HDL-C Levels Than WomenCeramide Scores Predict Cardiovascular Risk in the CommunityIntegrating lipidomics and genomics: emerging tools to understand cardiovascular diseasesRelationship between lipoproteins, thrombosis, and atrial fibrillationImpact of Blood Pressure Visit‐to‐Visit Variability on Adverse Events in Patients With Nonvalvular Atrial Fibrillation: Subanalysis of the J‐RHYTHM RegistryHow ApoB Measurements Could Improve Prevention of Cardiovascular DiseaseHDL-C and Cardiovascular Risk: You Don't Need to Worry about Extremely High HDL-C LevelsPravastatin‐induced changes in expression of long non‐coding and coding RNAs in endothelial cellsGut microbiota and cardiovascular disease: opportunities and challengesObesity-Related Changes in High-Density Lipoprotein Metabolism and FunctionLipoproteins-Nanocarriers as a Promising Approach for Targeting Liver Cancer: Present Status and Application ProspectsIcosapent ethyl: drug profile and evidence of reduced residual cardiovascular risk in patients with statin-managed LDL-C cholesterolComparison of different algorithms for the assessment of cardiovascular risk after kidney transplantation by the time of entering waiting listA Review of Lipidomics of Cardiovascular Disease Highlights the Importance of Isolating LipoproteinsHigh-Density Lipoproteins and Apolipoprotein A1A Compendium of the Biological Effects of Apolipoprotein A-I MilanoLDL como objetivo terapéuticoAssociation between high-density lipoprotein cholesterol and all-cause mortality in the general population of northern ChinaSocioeconomic status and education level are associated with dyslipidemia in adults not taking lipid-lowering medication: a population-based studyRare P376L variant in the SR-BI gene associates with HDL dysfunction and risk of cardiovascular diseaseRounding the corner on residual risk: Implications of REDUCE‐IT for omega‐3 polyunsaturated fatty acids treatment in secondary prevention of atherosclerotic cardiovascular diseaseLipid-lowering agents for the treatment of hyperlipidemia in patients with chronic kidney disease and end-stage renal disease on dialysis: a reviewUteroplacental Insufficiency Impairs Cholesterol Elimination in Adult Female Growth-Restricted Rat Offspring Fed a High-Fat DietMyocardial Infarction—From Atherosclerosis to ThrombosisCurrent pharmacotherapeutic options for primary dyslipidemia in adultsHDL Cholesterol as a Marker of Disease Severity and Prognosis in Patients with Pulmonary Arterial HypertensionGenome-wide association analysis of HDL-C in a Lebanese cohortCholesterol and Atherosclerotic Cardiovascular Disease: A Lifelong ProblemRisk Factor Variability and Cardiovascular OutcomeAllele-specific enhancers mediate associations between LCAT and ABCA1 polymorphisms and HDL metabolismThe Effects of a Physically Active Lifestyle on the Health of Former Professional Football PlayersMetabolomics and Heart Diseases: From Basic to Clinical ApproachAtherosclerosisIdentification of the first Tangier disease patient in Lebanon carrying a new pathogenic variant in ABCA1Structural Basis and Functional Mechanism of Lipoprotein in Cholesterol TransportUnravelling HDL—Looking beyond the Cholesterol Surface to the Quality WithinEfficacy and Safety of Ezetimibe and Rosuvastatin Combination Therapy Versus Those of Rosuvastatin Monotherapy in Patients With Primary HypercholesterolemiaAPPROACHES TO STATIN THERAPY ADHERENCE IMPROVEMENTClinical and pathophysiological evidence supporting the safety of extremely low LDL levels—The zero-LDL hypothesisLipoproteins for therapeutic delivery: recent advances and future opportunitiesLipoprotein in cholesterol transport: Highlights and recent insights into its structural basis and functional mechanismHDL Cholesterol Metabolism and the Risk of CHD: New Insights from Human GeneticsAssociation between High-density-lipoprotein-cholesterol Levels and the Prevalence of Asymptomatic Intracranial Arterial StenosisHistory of lipidology and lipoprotein apheresisCholesterol and Lipoprotein Metabolism and Atherosclerosis: Recent Advances in Reverse Cholesterol TransportTime to ditch HDL-C as a measure of HDL function?The Role of Omega-3 Fatty Acids in Reverse Cholesterol Transport: A ReviewAdvances in the management of dyslipidemiaPrevalence of Elevated Cardiovascular Risks in Young Adults: A Cross-sectional Analysis of National Health and Nutrition Examination SurveysKrishna K. Patel, MD, Glen B. Taksler, PhD, Bo Hu, PhD, and Michael B. Rothberg, MD, MPHHDL and macrophages: explaining the clinical failures and advancing HDL-based therapeutics in cardiovascular diseases?Potential and Caveats of Lipidomics for Cardiovascular DiseaseHigh-Density Lipoprotein Cholesterol and Cause-Specific Mortality in Individuals Without Previous Cardiovascular ConditionsHypercholesterinämie – Wo stehen wir heute? Wo wollen wir hin?Translational and Therapeutic Approaches to the Understanding and Treatment of DyslipidemiaImmunogenicity, Inflammation, and Lipid Accumulation in Cynomolgus Monkeys Infused with a Lipidated Tetranectin-ApoA-I Fusion ProteinNew Therapeutic Approaches to the Treatment of DyslipidemiaCausal Inference in Medicine via Mendelian RandomizationComparison of Adherence to Guideline-Based Cholesterol Treatment Goals in Men Versus WomenHDL-cholesterol and cardiovascular diseaseVariability in Low-Density Lipoprotein Cholesterol and Cardiovascular RiskHDL re-examinedThe role of T and B cells in human atherosclerosis and atherothrombosisHeart health: diets and lifestyleCholesterol ScreeningThe evidence base for fat guidelines: a balanced dietCardiac BiomarkersZebrafish as a model for apolipoprotein biology: comprehensive expression analysis and a role for ApoA-IV in regulating food intakeLxr-driven enterocyte lipid droplet formation delays transport of ingested lipidsHDL and cardiovascular diseaseHDL inhibits the effects of oxidized phospholipids on endothelial cell gene expression via multiple mechanismsOur obsession with saturated fats: is it time to rethink their role in the coronary artery disease?HDL Hypothesis: Where Do We Stand Now?Lipoprotein Subclasses and Cardiovascular Disease Risk in Insulin-Resistant DiabetesMR Imaging in Population-Based ResearchPretransplant dyslipidaemia determines outcome in lung transplant recipientsKorrektsiya dislipidemiy pri soputstvuyushchey arterial'noy gipertonii s pozitsiy obnovlennoy paradigmy serdechno-sosudistogo riskaRelationship of low- and high-density lipoproteins to coronary artery plaque composition by CT angiographyAtherosclerotic Heart DiseaseVascular disease and dementias: Paradigm shifts to drive research in new directionsPolyunsaturated fatty acyl-coenzyme As are inhibitors of cholesterol biosynthesis in zebrafish and miceAbdominal Obesity and Cardiovascular Disease: Is Inflammation the Missing Link?Mortalité coronarienne élevée à l’Île Maurice. Étude des facteurs de risque et analyses génomiquesMethods for Studying Rodent Intestinal Lipoprotein Production and MetabolismVisceral adiposity as a target for the management of the metabolic syndromeLipid Lowering in Coronary Artery DiseaseHypertriglyceridemic waist: missing piece of the global cardiovascular risk assessment puzzle?Improving lipid profiles and increasing use of lipid-lowering therapy in England: results from a national cross-sectional survey - 2006Clinical experience with rosuvastatin in the management of hyperlipidemia and the reduction of cardiovascular riskInformativeness of indices of blood pressure, obesity and serum lipids in relation to ischaemic heart disease mortality: the HUNT-II studyLipid parameters for measuring risk of cardiovascular diseaseThe Multiconstituent Cardiovascular Pill (MCCP): Challenges and Promises of Population Based Prophylactic Drug Therapy for Heart Attack Prevention and EradicationStroke: A Modern HistoryLayperson-Oriented versus Clinical-Based Models for Assessing 10-Year Incidence of Coronary Heart Disease: National FINRISK StudyThe Contribution of the Framingham Heart Study to the Prevention of Cardiovascular Disease: A Global PerspectiveStatins and inflammation: an updateStatin Effects on Both Low-Density Lipoproteins and High-Density Lipoproteins: Is There a Dual Benefit?Determinanten van ziekte en gezondheid op hoge leeftijd:Relation of Corneal Arcus to Cardiovascular Disease (from the Framingham Heart Study Data Set)Habitual consumption of eggs does not alter the beneficial effects of endurance training on plasma lipids and lipoprotein metabolism in untrained men and womenPhysicochemical basis of the digestion and absorption of triacylglycerolA Novel Clinical Entity: Triglyceride Deposit Cardiomyovasculopathy Implications and Perspectives from ''Obesity of the Heart''Smoking and smoking cessation—The relationship between cardiovascular disease and lipoprotein metabolism: A reviewAbdominal obesity: The cholesterol of the 21st century?Review Paper: Pathophysiology of Myocardial Reperfusion Injury: The Role of Genetically Engineered Mouse ModelsMorbidité et mortalité à 10 ans d’une cohorte de patients dyslipidémiques ayant consulté en centre hospitalierInfluencer la recherche pharmaceutique : un enjeu pour la connaissance des pathologiesAcute Myocardial Infarction and Acute Coronary Syndrome: Then and Now (1950-2005)Update on lipid-lowering therapy and LDL-cholesterol targetsSmoking, Heart Disease, and Lipoprotein MetabolismCalculating global risk: the key to interventionStatus of lipid-lowering therapy prescribedbased on recommendations in the 2002 report of the Japan Atherosclerosis Society Guideline for Diagnosis and Treatment of Hyperlipidemia in Japanese Adults: A study of the Japan Lipid Assessment Program (J-LAP)Omega-6 fatty acids and coronary artery disease: The pros and consTotal Cholesterol and Mortality in China, Poland, Russia, and the USEffectiveness of simvastatin therapy in raising HDL-C in patients with type 2 diabetes and low HDL-CThe effect of micronised fenofibrate on paraoxonase activity in patients with coronary heart diseaseEffects of Saengshik Supplementation on Health Improvement in Diet-Induced Hypercholesterolemic RatsTriglycerides, High-Density Lipoprotein Cholesterol, and Risk of Ischemic Heart Disease: A View from the Copenhagen Male StudyFrom interaction of lipidic vehicles with intestinal epithelial cell membranes to the formation and secretion of chylomicronsMaking practical sense of clinical trial data in decreasing cardiovascular riskEffect of the Angiotensin II Receptor Antagonist Valsartan on Lipid Profile and Glucose Metabolism in Patients with HypertensionEgg Consumption and Coronary Heart Disease: An Epidemiologic OverviewEffect of felodipine on the serum lipid profile of patients with hypertensionComment on Issues in the Assessment of Physical Activity in WomenLipid Lowering TherapyVino y corazónSynthesis of triphosphonate analogues of farnesyl pyrophosphate. Inhibitors of squalene synthase and protein:farnesyl transferaseLong-term Treatment With Pravastatin Alone and in Combination With Gemfibrozil in Familial Type IIB Hyperlipoproteinemia or Combined HyperlipidemiaHypercholesterolemia in the United States: How far have we come?Insulin resistance in essential hypertensive patients with impaired glucose toleranceLong-term treatment with simvastatin in patients with familial combined hyperlipidemiaLong-term metabolic effects of antihypertensive drugsLow-dose (5 mg) simvastatin versus gemfibrozil in the treatment of primary moderate hypercholesterolemia: Results of a belgian multicenter studyAntihypertensive and Antihyperlipidemic Effects of FunoranDoes Gallopamil Modify Blood Lipids?The Place of Alpha Blockers in the Antihypertensive ArmamentariumComparative trial of doxazosin and atenolol on cardiovascular risk reduction in systemic hypertensionEffects on Plasma Lipids during Long Term Antihypertensive Treatment with FelodipineHigh density lipoprotein cholesterol and total cholesterol in children with asthma and allergic rhinitisLipids and fatty acids and their relationship to restenosisVariability in Cholesterol Measurements in a Worksite Cholesterol Screening ProgramAngiographic Evolution of Coronary Atherosclerosis in Patients Receiving PropranololEffects of long-term verapamil therapy on serum lipids and other metabolic parametersUltrasound as Used in the Framingham Hearl StudyEstrogen replacement and cardiovascular disease: Serum lipids and blood pressure effectsManagement of blood lipid abnormalities in coronary heart disease patientsThe cholesterol controversy is over. Why did it take so long?Measurement of selected cardiovascular risk factors in childrenApolipoprotein, low density lipoprotein subfraction, and insulin associations with familial combined hyperlipidemia. Study of Utah patients with familial dyslipidemic hypertension.Lovastatin in the Treatment of Multifactorial Hyperlipidemia Associated With ProteinuriaCan Risk Scores for Vascular Disease in Gout Patients be Improved?Nutritional requirements of the agedSerum lipids and lipoproteins after myocardial infarction: Associations with cardiovascular mortality and experience in the Aspirin Myocardial Infarction StudyBeta-Blocking Agents and Plasma Lipids: An UpdateGeographical distribution of cerebrovascular disease mortality and food intakes in JapanTreatment of the Hyperlipidemia of the Nephrotic Syndrome: A Controlled TrialSerum apolipoproteins AI and B and lipoproteins in middle aged men with and without previous myocardial infarction.Plasma triglycerides related decrease in high-density lipoprotein cholesterol and its association with myocardial infarction in heterozygous familial hypercholesterolemiaNutritional Value of LipidsPathogenesis of Coronary Atherosclerosis: Prevention of AtherogenesisEffect of Brazilin on Plasma Lipid Levels in Spontaneously Hypertensive RatsEND-ORGAN RESPONSES TO THYROXINE THERAPY IN SUBCLINICAL HYPOTHYROIDISMRenal handling of plasma high density lipoproteinEffects of Red ginseng-crude saponin on plasma lipid levels in rats fed on a diet high in cholesterol and triglycerideMetabolic disturbances increasing the risk of coronary heart disease during diuretic-based antihypertensive therapy: Lipid alterations and glucose intoleranceEffect of trimazosin on serum lipid profiles in hypertensive patientsSome wrong-way chemical changes during antihypertensive treatment: Comparison of indapamide and related agentsEarly indicators for the risk of atherogenesis a field test of a new methodology on kindergarten children in DüsseldorfRisk factors for pulmonary embolismHypolipidemic activity and toxicity studies of a styrl-hexahydroindolinol, 34–250Vascular mortality in patients with gout and in their families.Perioperative Cardiac CareCord blood serum in newborns of diabetic mothersCigarette smoking: Carboxyhemoglobin, plasma nicotine, cotinine and thiocyanate vs self-reported smoking data and cardiovascular diseaseAdipose tissue fatty acid composition of adolescents in a U.S.-Greece cross-cultural study of coronary heart disease risk factorsIntra-individual variation of serum cholesterol, triglycerides and high density lipoprotein cholesterol in normal humansEffect of Gemfibrozil on Serum Lipids in ManBeziehungen zwischen Lipidstoffwechsel und glycosylierten Hämoglobinen beim juvenilen Diabetes mellitusChanges of systolic time intervals in asymptomatic patients with primary hyperlipoproteinemiaAdverse Effects of Some Food LipidsIntroductionChenodiol (Chenodeoxycholic Acid) for Dissolution of Gallstones: The National Cooperative Gallstone Study A Controlled Trial of Efficacy and SafetyLESLIE J. SCHOENFIELD, M.D., Ph.D, JOHN M. LACHIN, Sc.D., RICHARD A. BAUM, M.D., ROBERT L. HABIG, Ph.D., RUSSELL F. HANSON, M.D., THEODORE HERSH, M.D., N. C. HIGHTOWER Jr., M.D., ALAN F. HOFMANN, M.D., ELLIOT C. LASSER, M.D., JAY W. MARKS, M.D., HAGOP MEKHJIAN, M.D., RONALD OKUN, M.D., ROBERT A. SCHAEFER, M.D., LAWRENCE SHAW, ROGER D. SOLOWAY, M.D., JOHNSON L. THISTLE, M.D., FRED B. THOMAS, M.D., MALCOLM P. TYOR, M.D.Pediatric aspects of atherosclerosisPlasma apolipoprotein B and VLDL-, LDL-, and HDL- cholesterol as risk factors in the development of coronary artery disease in male patients examined by angiographyZum Einfluß einer Fettdiät auf den Gehalt an Gesamtcholesterol, freiem Cholesterol und Estercholesterol in Serum und Leber von RattenRole of lipids and lipoprotein fractions in atherogenesis: The framingham studyLEVELS AND LIPID COMPOSITION OF THE MAJOR LIPOPROTEIN CLASSES IN CORONARY AND CEREBRAL ATHEROSCLEROTIC PATIENTSCombined effect of cholesterol feeding and sympathectomy on the lipid content in rabbit aortasThe State of School Heart Health Education: A Review of the LiteratureKnowledge and health practices of high school students with respect to heart disease risk factors—a pilot studyLow Density Lipoproteins in the Aorta: Relation to AtherosclerosisFatty Acid Composition of Human Serum Lipids at BirthIncreasing Students' Knowledge of Cancer and Cardiovascular PreventionComparison of high density lipoprotein and serum cholesterol levels in a European and an African communityThe effects of a vegetarian and vegan diet on plasma and erythrocyte lipidsNature of the familial influence on plasma lipid levelsHigh Density and Low Density Lipoproteins in Chronic Renal Failure Before and After Renal TransplantationSudden Death and Cardiac DiseaseNormocholesterolemic dysbetalipoproteinemia with xanthomatosisConcentration and composition of human serum lipoproteins at birthCopper deficiency and cholesterol metabolism in the ratA co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Report from the Committee of Principal Investigators.Tracking of blood lipids and blood pressures in school age children: the Muscatine study.The effect of garri on rat plasma cholesterolExperimental hyper-β-lipoproteinemia and its amelioration by a novel hypolipidemic agentNewer concepts in antihypertensive drugsOn the concept of the normal rangeUsefulness of serum lipid determination in diabetic practiceAtherosclerosis, Hypothyroidism, and Thyroid Hormone TherapyConcomitants of atherosclerotic carotid artery stenosis.Hypertriacylglycerolemia in the chick: Effect of estrogen on hepatic microsomal enzymes of triacylglycerol and phospholipid synthesisSerum lipid levels in a clerical workforceINFLUENCE OF LIPID CONCENTRATIONS AND AGE ON TRANSFER OF PLASMA LIPOPROTEIN INTO HUMAN ARTERIAL INTIMAHigh density lipoproteins in ischaemic heart diseaseDiet, heredity and heart diseaseDiabetes mellitus und HyperlipoproteinämieEffects of Diuretics On Lipid Metabolism in Patients With Essential HypertensionSerum lipid profiles in patients of myocardial infarction in the Chandigarh area (Northern India)A practical management of hypertensionRelationship of plasma uric acid to plasma lipids and lipoproteins in subjects with peripheral vascular diseaseDEATH FROM ISCHÆMIC HEART-DISEASE AND MALIGNANCY IN ADULT PATIENTS WITH CŒLIAC DISEASEApolipoprotein localization in human cranial arteries, coronary arteries, and the aorta.Independence of blood pressure and plasma cholesterol in miceHyperlipidæmia in Scotland and the Role of Drug TreatmentStudies on Subclinical Hypothyroidism with Special Reference to the Serum Lipid PatternEffect of Bilateral Oophorectomy and Peroral Estradiol Valerate Therapy on Serum LipidsApo-Lipoprotein Localization in Human Atherosclerotic ArteriesAlcoholic HyperlipemiaCholesterinReduction of serum lipids by means of etiroxate (liponorm®)The Hyperlipoproteinemias in AdolescenceFREQUENCY OF ISCHÆMIC EXERCISE E.C.G. CHANGES IN SYMPTOM-FREE MEN WITH VARIOUS FORMS OF PRIMARY HYPERLIPÆMIAQuantitative and qualitative serum lipoprotein analysisCoronary heart disease risk factors in school children: The Muscatine studyPlasma lipid values and lipoprotein patterns during adolescence in boysFUNCTIONAL ROLE OF CHOLESTEROL IN INFECTION AND AUTOIMMUNITYStudies in Asymptomatic Primary HyperlipidaemiaExercise Stress Testing in Patients with Chest Pain and Normal Coronary Arteriography: With Review of the LiteratureCholesterol Metabolism in Man4 Antihyperlipidaemic AgentsSerum Lipid Levels and Thromboembolic Complications During Estrogen Therapy of Prostatic CancerThe importance of type IV hyperlipoproteinemia as a predisposing factor in coronary artery diseaseEffect of diet on hepatic and intestinal lipogenesis in squirrel, Cebus, and cynomolgus monkeysDIETARY FACTORS AND ATHEROSCLEROSIS: PREVENTION SHOULD BEGIN EARLYRole of Lipids in the Development of Brain Infarction: The Framingham StudyRelationship of plasma lipids and lipoprotein concentration to cerebral atherosclerosis and electrocardiographic findingsEpidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: Demographic, physical, dietary and biochemical characteristicsEffect of phenformin on lipid transport in hypertriglyceridemiaRenal Failure, Hypertriglyceridemia, and Coronary DiseaseCoronary heart disease as a pediatric problem prevention through behavior modificationProduction of plasma esterified cholesterol in lean, normotriglyceridemic humansSerum cholesterol and triglyceride levels in human populations from Guatemala city and New OrleansFREQUENCY OF RISK FACTORS FOR ISCHÆMIC HEART-DISEASE IN A HEALTHY BRITISH POPULATIONSerum lipids, dietary intakes, and physical exercise in medical students1Metabolic Aspects of Physical Training in Male Patients after Myocardial InfarctionThe application of electrocardiographic screening and exercise testing to preventive cardiologySignificance of Increased Serum Pre-Beta Lipoproteins in Myocardial InfarctionPeripheral arterial occlusion in patients with acute coronary heart diseaseThe Correlation of Coronary Angiography and the Electrocardiographic Response to Maximal Treadmill Testing in 76 Asymptomatic MenHyperlipoproteinaemia and peripheral vascular diseaseManagement of the Hyperlipidemic PatientDer Cholesterinspiegel im Plasma gesunder Menschen und seine Beeinflussung durch hohe Dosen L(+)-AscorbinsäureImpairment of the Diurnal Fibrinolytic Response in ManPossible acute liver toxicity from the hypolipidemic agent 1-methyl-4-piperidyl-bis(p-chlorophenoxy)-acetateThe Effect of Sodium Dextrothyroxine On Serum Cholesterol and Mortality Rates in Cardiac PatientsCerebrovascular disease and hyperlipoproteinemiaDie arterielle Durchblutungsreserve bei Patienten mit essentiellen HyperlipoproteinämienCOMPLICATIONS DURING CLOFIBRATE TREATMENT OF NEPHROTIC-SYNDROME HYPERLIPOPROTEINÆMIAEpidemiology of serum lipids in Southern AfricaThe role of endogenous insulin in different hyperlipidemic statesHyperlipoprotein�mien und CoronarerkrankungenLIPID ABNORMALITIES IN MALE AND FEMALE SURVIVORS OF MYOCARDIAL INFARCTION AND THEIR FIRST-DEGREE RELATIVESThe Relationship between Serum Lipid Abnormalities and Other Major Risk Factors in Myocardial InfarctionInvestigation of Changes in Clinical Laboratory Tests Related to Aging and SmokingClinical Evaluation in the Normative Aging StudyHäufigkeit von Hyperlipoproteinämien bei Patienten mit ischämischem cerebralen InsultAtrophic Thyroiditis, Hypertension and Coronary Heart DiseasePrevalence of Plasma Lipoprotein Abnormalities in a Free-Living Population of the Central Valley, CaliforniaThe Natural History of Congestive Heart Failure: The Framingham StudyThe incidence of plasma insulin, blood sugar and serum lipid abnormalities in patients with atherosclerotic diseaseThe Coronary ArteriogramSERUM LIPIDS AND LIPOPROTEINS IN PERIPHERAL VASCULAR DISEASEArterial blood pressure and the manifestation of atherosclerosis in a rural population of North BohemiaPlasma phosphatidylethanolamine — A better indicator in the predictability of atherosclerotic complications?Systolic versus diastolic blood pressure and risk of coronary heart diseaseSerum lipid precursors of coronary heart diseaseHYPERLIPOPROTEINÆMIAS IN NEPHROTIC SYNDROMEThe Treatment of HyperlipidemiaDISTRIBUTION OF SERUM LIPIDS IN NORWEGIAN RECRUITSSerum Cholesterol, Lipoproteins, and the Risk of Coronary Heart Disease The Framingham StudyWILLIAM B. KANNEL, M.D., WILLIAM P. CASTELLI, M.D., TAVIA GORDON, PATRICIA M. MCNAMARAClinical aspects of lipid metabolismDiabetes e hiperlipoproteinemia en la enfermedad aterosclerosa del coraz�nCoronary Disease and Carbohydrate and Fat AbnormalitiesAntihyperlipidemic AgentsDetection of individual susceptibility toward coronary diseasePrevention of myocardial infarctionLipoprotein PhenotypingNutrition and Cardiovascular DiseaseA study of the primary prevention of coronary heart disease.Hyperlipidemia in Atherosclerosis: Dietary and Drug TreatmentIntermittent ClaudicationCholesterol, Atherosclerosis, Ischemic Heart Disease, and StrokeSEYMOUR DAYTON, M.D., JOHN M. CHAPMAN, M.D., MORTON LEE PEARCE, M.D., GEORGE J. POPJÁK, M.D.Results of the Epidemologic Investigation of Ischaemic Heart Disease: Illustrated by the Framingham StudyRISKS OF ISCHÆMIC HEART-DISEASE IN FAMILIAL HYPERLIPOPROTEINÆMIC STATESSTERILITY OF EYE-DROPSCARDIAC TRANSPLANTATION, CORONARY ATHEROMA, AND ISCHÆMIC HEART-DISEASEFamilial Type IV HyperlipoproteinemiaFASTING SERUM TRIGLYCERIDE, CHOLESTEROL, AND LIPOPROTEIN LEVELS DURING ORAL-CONTRACEPTIVE THERAPYMetabolic Effects of Oral ContraceptivesA Shifting CurveLipid and carbohydrate abnormalities in patients with angiographically documented coronary artery diseaseMetabolic basis of human atherosclerosisBlood Pressure and Risk of Coronary Heart Disease: The Framingham StudyEstrogens in the Menopause and PostmenopauseMYOCARDIAL INFARCTION IN EARLY AGEFasting Serum Triglyceride and Cholesterol Levels During Oral Contraceptive TherapyHypolipidemic AgentsCoronary heart disease in HawaiiInterrelationships of Hyperinsulinism and Hypertriglyceridemia in Young Patients with Coronary Heart DiseasePROPHYLAXIS OF CORONARY HEART DISEASE, STROKE, AND PERIPHERAL ATHEROSCLEROSISPrevention of heart failureTissue changes in experimental chronic endogenous hyperlipemiaMETABOLIC ABNORMALITIES IN PREMATURE CORONARY DISEASE: EFFECTS OF THERAPYCoronary Heart Disease: Screening by Familial AggregationTHE PREVENTION OF CORONARY HEART DISEASEMyxedema and Coronary Artery Disease—A Comparative Autopsy StudyALFRED D. STEINBERG, M.D.Current Metabolic-Genetic Interrelationship in Human Atherosclerosis With Therapeutic ConsiderationsPETER T. KUO, M.D., F.A.C.P.REFERENCESEFFECT OF A SINGLE DOSE OF NICOTINIC ACID ON PLASMA LIPIDS IN PATIENTS WITH HYPERLIPOPROTEINEMIADiagnostic value of serum lipids and frequency of lipoprotein patterns in myocardial infarctionBlood Lipids in Man—A Brief ReviewMyocardial Infarction Among Southwestern American IndiansMAURICE L. SIEVERS, M.D., F.A.C.P.The pathogenesis of atherosclerotic complications in manPREVENTION OF CORONARY HEART DISEASEDietary Fats, Carbohydrates and Atherosclerotic Vascular DiseaseSerum Insulin, Carbohydrate, and Lipid Abnormalities in Patients with Premature Coronary Heart DiseaseMANUEL TZAGOURNIS, M.D., JOHN F. SEIDENSTICKER, M.D., GEORGE J. HAMWI, M.D., F.A.C.P.The influence of dietary regimens on serum fat in atherosclerotic subjectsCoronary angiography in the clinical analysis of suspected coronary diseaseSerum low-density lipoprotein levels in a New Zealand population samplePrimary prevention of coronary heart disease by dietA clinical evaluation of coronary arteriographyDIETARY FAT AND CORONARY HEART DISEASE: A REVIEWSerum Lipids, Nutrition and Atherosclerotic Complications in ManThe prevention of coronary heart diseaseCardiovascular Disease, Diabetes Mellitus, and Anthropometric Evaluation of Polynesian Males on the Island of Niihau-1963Presymptomatic Diagnosis of Ischæmic Heart DiseaseSOME EFFECTS OF ORAL CONTRACEPTIVES ON SERUM-LIPID AND LIPOPROTEIN LEVELSCoronary Angiographic Findings in Correlation with Age, Body Weight, Blood Pressure, Serum Lipids, and Smoking HabitsThe development of coronary heart disease in relation to sequential biennial measures of cholesterol in the framingham studyA Study of Coronary Heart Disease in Young MenControl of dietary fat in relation to diabetic complications in childrenAn assessment of the utility of the resting apex cardiogram in the epidemiology of cardiovascular diseaseTHE PRECURSORS OF HYPERTENSION AND CORONARY ARTERY DISEASE: INSIGHTS FROM STUDIES OF BIOLOGICAL VARIATIONBIBLIOGRAPHYThe Physician's Incompleat Guide to AtherosclerosisIRVINE H. PAGE, M.D., F.A.C.P., JEROME G. GREEN, M.D., ABEL LAZZARINI ROBERTSON, M.D., PH.D.Risikofaktoren beim HerzinfarktSymposium: Advances in Detection of Coronary Artery DiseaseCoronary Thrombosis Its Mechanism and Possible Prevention by Linolenic AcidP. A. OWREN, M.D. 1 November 1964Volume 61, Issue 5_Part_1Page: 888-899KeywordsCholesterolCongenital heart diseaseCoronary heart diseaseEpidemiologyHypertensionLongitudinal studiesMedical risk factorsMedical servicesOintmentsPrevention, policy, and public health Issue Published: 1 November 1964 PDF DownloadLoading ...